Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1984 8
1985 6
1986 13
1987 14
1988 9
1989 5
1990 12
1991 9
1992 10
1993 11
1994 14
1995 9
1996 17
1997 13
1998 15
1999 15
2000 18
2001 13
2002 13
2003 20
2004 19
2005 19
2006 8
2007 10
2008 9
2009 12
2010 9
2011 12
2012 10
2013 6
2014 9
2015 18
2016 10
2017 8
2018 10
2019 8
2020 11
2021 14
2022 13
2023 12
2024 20
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

466 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, Miller AC, Paul SM, Brannan SK. Kaul I, et al. Among authors: breier a. Lancet. 2024 Jan 13;403(10422):160-170. doi: 10.1016/S0140-6736(23)02190-6. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104575 Clinical Trial.
Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study.
Weiden PJ, Breier A, Kavanagh S, Miller AC, Brannan SK, Paul SM. Weiden PJ, et al. Among authors: breier a. J Clin Psychiatry. 2022 May 11;83(3):21m14316. doi: 10.4088/JCP.21m14316. J Clin Psychiatry. 2022. PMID: 35552528 Free article. Clinical Trial.
Muscarinic Receptor Activators as Novel Treatments for Schizophrenia.
Paul SM, Yohn SE, Brannan SK, Neugebauer NM, Breier A. Paul SM, et al. Among authors: breier a. Biol Psychiatry. 2024 Oct 15;96(8):627-637. doi: 10.1016/j.biopsych.2024.03.014. Epub 2024 Mar 25. Biol Psychiatry. 2024. PMID: 38537670 Free article. Review.
A preliminary choroid plexus volumetric study in individuals with psychosis.
Senay O, Seethaler M, Makris N, Yeterian E, Rushmore J, Cho KIK, Rizzoni E, Heller C, Pasternak O, Szczepankiewicz F, Westin CF, Losak J, Ustohal L, Tomandl J, Vojtisek L, Kudlicka P, Kikinis Z, Holt D, Lewandowski KE, Lizano P, Keshavan MS, Öngür D, Kasparek T, Breier A, Shenton ME, Seitz-Holland J, Kubicki M. Senay O, et al. Among authors: breier a. Hum Brain Mapp. 2023 Apr 15;44(6):2465-2478. doi: 10.1002/hbm.26224. Epub 2023 Feb 6. Hum Brain Mapp. 2023. PMID: 36744628 Free PMC article.
New insight into p-glycoprotein as a drug target.
Breier A, Gibalova L, Seres M, Barancik M, Sulova Z. Breier A, et al. Anticancer Agents Med Chem. 2013 Jan;13(1):159-70. Anticancer Agents Med Chem. 2013. PMID: 22931413 Review.
Normative modelling of brain morphometry across the lifespan with CentileBrain: algorithm benchmarking and model optimisation.
Ge R, Yu Y, Qi YX, Fan YN, Chen S, Gao C, Haas SS, New F, Boomsma DI, Brodaty H, Brouwer RM, Buckner R, Caseras X, Crivello F, Crone EA, Erk S, Fisher SE, Franke B, Glahn DC, Dannlowski U, Grotegerd D, Gruber O, Hulshoff Pol HE, Schumann G, Tamnes CK, Walter H, Wierenga LM, Jahanshad N, Thompson PM, Frangou S; ENIGMA Lifespan Working Group. Ge R, et al. Lancet Digit Health. 2024 Mar;6(3):e211-e221. doi: 10.1016/S2589-7500(23)00250-9. Lancet Digit Health. 2024. PMID: 38395541 Free PMC article. Review.
466 results